|
Market Closed -
Deutsche Boerse AG
13:33:56 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 9.112 EUR | +0.24% |
|
+3.17% | +27.58% |
| 08-20 | Will Moderna Wake Up the Health Care Sector? | |
| 06-11 | IShares IV Public Limited Company Announces Interim Distribution for 2026, Payable on 30 June 2026 | CI |
Main features
| IE00BYXG2H39 | Fees | 0.35% | Dividend Policy | Market Cap | |
|---|---|---|---|---|---|
| Currency | EUR | AuM (CAD) | 1.69B | Replication Method | Direct (Physical) |
| Number of securities | 252 | AuM evolution | - | Date of creation | 2017-10-18 |
Deutsche Boerse AGEUR
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| BTEK | Delayed | |
Xetra
| 2B70 | Delayed | |
Swiss Exchange
| BTEC | Delayed | |
London S.E.
| BTEK | Delayed | |
Tradegate
| 2B70 | Real-time | |
Boerse Muenchen
| 2B70 | Real-time | |
Börse Stuttgart
| 2B70 | Delayed | |
Swiss Exchange
| BTEC | Delayed | |
OTC Markets
| IVBUF | Delayed | |
CBOE
| BTEK | Real-time | |
Deutsche Boerse AG
| 2B70 | Delayed | |
CBOE
| BTEK | Real-time | |
Swiss Exchange
| BTEC | Delayed | |
CBOE
| BTEK | Real-time | |
CBOE
| Real-time |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | United States |
| Theme and Sector | Biotechnology, Pharmaceuticals |
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | €9.112 | +0.24% | 0 |
| 26-10-22 | €9.090 | -1.56% | 70 |
| 26-10-21 | €9.234 | +0.08% | 2,700 |
| 26-10-20 | €9.227 | +3.03% | 500 |
| 26-10-19 | €8.956 | +1.40% | 407 |
- Stock Market
- ETF
- 2B70 ETF
Select your edition
All financial news and data tailored to specific country editions






















